Abstract
In order to take ethical considerations of patenting biological material into account, the so-called “ordre public or morality clause” was implemented as Article 6 in the EC directive on the legal protection of biotechnological inventions, 98/44/EC. At first glance, this seems to provide a significant advantage to the European patent system with respect to ethics. The thesis of this paper argues that the ordre public or morality clause does not provide sufficient protection against ethically problematic uses of the patent system within the area of life. On the contrary, there are worrisome obstacles to any effective and comprehensive critical analysis of the ethical aspects of bio-patenting, especially in the field of agriculture. These obstacles can be seen as indirect consequences of the implementation of ethical considerations in form of the ordre public and morality clause in the EC Directive. Therefore, Article 6 of the EC Directive on the legal protection of biotechnological inventions seems to ultimately weaken the position of ethics in the debate concerning bio-patenting because the ordre public and morality clause is usually interpreted in an exclusively bio-ethical way in the sense of an “intrinsic ethics,” which is primarily interested in questions regarding the moral status of particular entities. It is argued that an important cause of this phenomenon is that the decisive reasons against bio-patenting are concerns of social ethics, and not bio-ethics.
Article PDF
Similar content being viewed by others
References
Bagley M. (2003) Patent first, ask questions later: Morality and Biotechnology in Patent Law. William and Mary Law Review 45:469–547
Baumgartner C., Mieth D. (eds) (2003) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag
Baumgartner C., Mieth D., (2006) Biopatentierung–Ziele, Probleme und ethische Aspekte. In: Hilpert K., Mieth D. (eds) Kriterien biomedizinischer Ethik. Freiburg, Herder-Verlag, pp. 275–291
Van den Belt H., (2003) Enclosing the Genetic Commons: Biopatenting on a Global Scale. In: Baumgartner C., Mieth D. (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 229–243
Beyleveld D., Brownsword R., (2003) Is Patent Law Part of the EC Legal Order? A Critical Commentary on the Interpretation of Article 6(1) of directive 98/44/EC in Case C-377/98. In: Baumgartner C., Mieth D., (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 129–143
Brom F., (2003) The Expressive-Communicative Function of Bio-Patent Legislation: the Need for Further Public Debate. In: Baumgartner C., Mieth D., (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 117–126
Cole-Turner R., (2000) Patents and Licensing, Ethics, Organizations with Prominent Positions on Gene Patenting. In: Murray T. H., Mehlman M. J. (eds) Encyclopedia of ethical, legal and policy issues in Biotechnology, Volume 2. New York, Wiley, pp. 834–844
Coopération Internationale pour le Développement et la Solidarité (CIDSE). Biopatenting and the Threat to Food Security. A Christian and Development Perspective. Edited by B. van Dillen and M. Leen (Brussels, 2000)
Commission on Intellectual Property Rights (CIPR) (2002) Integrating Intellectual Property Rights and Development Policy. Report, London
Cunningham P. C. (2003) Is it Right or is it Useful? Patenting of the Human Gene, Lockean Property Rights, and the Erosion of the Imago Dei. Ethics & Medicine 19: 85–98
Directive 98/44/EC of the European Parliament and of the Council of 6 July 1998 on the legal protection of biotechnological inventions; in Official Journal of the European Communities L 213, 30/07/1998, 13–21
Dolder F., Patente und Patentierungsverbote für menschliche Stammzellen, unpublished manuscript, (2003)
Eisenberg R. S. (2002) How Can You Patent Genes?. American Journal of Bioethics 2(3):3–11
German National Ethics Council (GNEC) (2004) The Patenting of biotechnological inventions involving the use of biological material of human origin. Opinion, Berlin
Gewirth A., (1978) Reason and Morality. Chicago, The University of Chicago Press
Godt C., Streit um den Biopatentschutz: Stoffschutz, Patente auf Leben und Ordre Public. Nationaler Gestaltungsspielraum bei der Umsetzung der Europäischen Biopatentrichtlinie. Discussion Paper of the Centre of European Law and Politics at the University of Bremen (ZERP) (Bremen, 2003)
Habermas J. (1996) Between Facts and Norms. Contributions to a Discourse Theory of Law and Democracy. Cambridge, Polity Press
Heller M. A., Eisenberg R. S., (1998) Can Patents Deter Innovation? The Anticommons in Biomedical Research. Science 280(1 May):698–701
Hermerén G., (2000) Patents and licensing, Ethics, international controversies. In: Murray T. H., Mehlman M. J. (eds) Encyclopedia of Ethical, Legal and Policy Issues in Biotechnology, Volume 2. New York, Wiley, pp. 817–825
Kevles D. J. (2002) A history of Patenting life in the United States with comparative attention to Europe and Canada. Report to the European Group on Ethics in Science and New Technologies
Laudien D., (2003) Warum brauchen wir Biopatente?. In: Baumgartner C., Mieth D. (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 45–57
Nilles B., (2003) Biopatente aus entwicklungspolitischer Perspektive. In: Baumgartner C., Mieth D. (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 213–227
Van Overwalle G, (2003) Legal and Ethical Aspects of Bio-Patenting. Critical analysis of the EU Biotechnology Directive. In: Baumgartner C., Mieth D. (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 145–157
Schneider I., (2003) Funktionsgebundener Stoffschutz auf DNA-Sequenzen?. In: Baumgartner C., Mieth D. (eds) Patente am Leben? Ethische, rechtliche und politische Aspekte der Biopatentierung. Paderborn, mentis-Verlag, pp. 179–212
Spranger T. M., (1999) Ethische Aspekte bei der Patentierung menschlichen Erbguts nach der Richtlinie 98/44/EG. Gewerblicher Rechtsschutz und Urheberrecht, Internationaler Teil, pp. 595–598
Spranger T. M., (2003) Die Biopatent-Debatte–kein Ende in Sicht?. Zeitschrift für Biopolitik 2: 85–88
Svatos M., (2000) Patents and Licensing, Ethics, Ownership of Animal, and Plant Genes. In: Murray T. H., Mehlman M. J. (eds) Encyclopedia of Ethical, Legal and Policy Issues in Biotechnology, Volume 2. New York, Wiley, pp. 844–854
Tsioumanis A., Mattas K., Tsioumani E., (2003) Is Policy Towards Intellectual Property Rights Addressing the Real Problems? The Case of Unauthorized Appropriation of Genetic Resources. Journal of Agricultural and Environmental Ethics 16: 605–616
Warner K. D., (2001) Are Life Patents Ethical? Conflict Between Catholic Social Teaching and Agricultural Biotechnology’s Patent Regime. Journal of Agricultural and Environmental Ethics 14:301–319
Wolfrum R., Stoll P.-T., (2001). Die Gewährleistung freier Forschung an und mit Genen und das Interesse an der wirtschaftlichen Nutzung ihrer Ergebnisse. Expert’s opinion, Heidelberg and Göttingen
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This is an open access article distributed under the terms of the Creative Commons Attribution Noncommercial License ( https://creativecommons.org/licenses/by-nc/2.0 ), which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.
About this article
Cite this article
Baumgartner, C. Exclusion by Inclusion? On Difficulties with Regard to an Effective Ethical Assessment of Patenting in the Field of Agricultural Bio-Technology. J Agric Environ Ethics 19, 521–539 (2006). https://doi.org/10.1007/s10806-006-9006-9
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10806-006-9006-9